6RABOUD J M, HARRIS M, RAE S, et al. Impact of adherence on duration of virological suppression among patients receiving combination antiretroviral therapy[J]. HIV Med,2002,3(2) :118-124.
7Centers for Disease Control and Prevention. 1993 revised classification system for HIV infection and expanded surveillance case definition for AIDS among adolescents and adults[J]. MMWR Recomm Rep, 1992,41(RR-17) : 1-19.
8Rowland-Jones SL Timeline: AIDS pathogenesis What have two decades of HIV research taught us? [J]. Nat Rev Immunology, 2003,3(4):343-348.
9Lewden C, Salmon D, Morlat P, et al. Cause of death among human immunodeficiency virus (HIV)-infected adults in the era of protect an-tiretroviral therapy: Emerging role of hepatitis and cancers, persistent role of AIDS[J]. Int Epidemiology, 2004,12(23):1521-1530.
10Montaner JS, Reiss P, Cooper D, et al. A randomized, double-blind trial comparing combinations of nevirapine, didanosine, and zidovudine for HIV-infected patients: The INCAS Trial,Italy,The Netherlands, Canada and Australia Study[J]. JAMA,1998,279(12):930-937.
8Chu Y,Liu H.Advances of research on anti-HIV agents from traditional Chinese herbs[J].Adv Dent Res,2011,23(1):67.
9Langlois-Klassen D,Kipp W,Rubaale T.Who’s talking Communication between health providers and HIV-infected adults related to herbal medicine for AIDS treatment in western Uganda[J].Soc Sci Med,2008,67(1):165.
10Dhalla S,Chan KJ,Montaner JS,et al.Complementary and alternative medicine use in British Columbia:a survey of HIV positive people on antiretroviral therapy[J].Complement Ther Clin Pract,2006,12(4):242.
